The remote blood-draw dried-spot device market size has grown rapidly in recent years. It will grow from $0.92 billion in 2025 to $1.05 billion in 2026 at a compound annual growth rate (CAGR) of 13.5%. The growth in the historic period can be attributed to growth in remote diagnostics, need for patient convenience, expansion of lab testing services, newborn screening programs, telemedicine growth.
The remote blood-draw dried-spot device market size is expected to see rapid growth in the next few years. It will grow to $1.73 billion in 2030 at a compound annual growth rate (CAGR) of 13.2%. The growth in the forecast period can be attributed to home healthcare expansion, chronic disease monitoring, digital pathology growth, logistics optimization, population health management. Major trends in the forecast period include at-home blood sample collection, mail-in diagnostic testing, minimal invasive sampling devices, microfluidic blood collection, decentralized diagnostic testing.
The growing emphasis on personalized medicine is expected to drive the growth of the remote blood-draw dried-spot device market in the coming years. Personalized medicine involves tailoring medical treatments and preventive strategies based on an individual’s unique genetic, molecular, and clinical characteristics to achieve better health outcomes. The adoption of personalized medicine is increasing as advances in genomics make it possible to identify genetic variations that influence disease susceptibility and treatment response, enabling more targeted and effective therapies. Remote blood-draw dried-spot devices support this approach by allowing convenient, at-home collection of small blood samples, facilitating frequent monitoring of biomarkers and genetic information to guide individualized treatment decisions. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, the FDA approved 16 new personalized treatments for rare disease patients in 2023, up from six in 2022. These approvals included seven cancer therapies and three for other conditions. Therefore, the rising focus on personalized medicine is driving the growth of the remote blood-draw dried-spot device market.
Major companies in the remote blood-draw dried-spot device market are developing advanced decentralized sampling solutions to enable at-home blood collection, enhance patient convenience, and improve clinical trial efficiency. Decentralized sampling involves collecting biological samples outside traditional clinical settings, such as at home or in local facilities, allowing broader participation, faster sample turnaround, and improved data accessibility. For example, in March 2025, Tasso Inc., a US-based healthcare technology company, introduced next-generation dried blood spot (DBS) sampling technology designed for clinical trials and sports anti-doping testing. This innovation provides a virtually painless, accurate, and user-friendly method for blood collection, enabling precise volumetric sampling and high-quality data generation. By simplifying the sampling process and reducing participation barriers, the technology enhances compliance, accelerates drug development, and supports decentralized healthcare and research models.
In April 2025, Boston, a US-based biotechnology company, partnered with Nanowear Inc. to develop advanced wearable biosensors for continuous health monitoring. The collaboration aims to transform home-based healthcare by integrating AI-powered nanotechnology diagnostics with blood-based sampling and drug delivery patches. This combined digital health platform enables precise, continuous, and patient-friendly diagnostics and therapeutics, promoting the shift from clinic-centered to decentralized personalized care. Nanowear Inc., a US-based technology company, offers remote blood-draw dried-spot devices that complement these innovations in wearable biosensing and digital health monitoring.
Major companies operating in the remote blood-draw dried-spot device market are Neoteryx Inc., DBS System SA, Tasso Inc., Capitainer AB, Spot On Sciences Inc., HemaXis S.A., Drawbridge Health Inc., RDA Spot Inc., YourBio Health Inc., Lipomic Healthcare Inc., Trajan Scientific and Medical Pty Ltd., Salimetrics LLC, Eastern Business Forms Inc., PanoHealth Inc., RedDrop Dx Inc., Nanowear Inc., Bioanalytical Systems Inc., Phenomenex Inc., Greiner Bio-One International GmbH, Whatman (Cytiva)
North America was the largest region in the remote blood-draw dried-spot device market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the remote blood-draw dried-spot device market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the remote blood-draw dried-spot device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have increased costs of microfluidic components, filter papers, and plastic consumables used in dried-spot blood collection devices, particularly affecting manufacturers in Asia-Pacific supplying global markets. While tariffs have raised operational costs, they are also accelerating regional production, eco-friendly materials, and innovation in compact diagnostic sampling solutions.
The remote blood-draw dried-spot device market research report is one of a series of new reports that provides remote blood-draw dried-spot device market statistics, including remote blood-draw dried-spot device industry global market size, regional shares, competitors with a remote blood-draw dried-spot device market share, detailed remote blood-draw dried-spot device market segments, market trends and opportunities, and any further data you may need to thrive in the remote blood-draw dried-spot device industry. This remote blood-draw dried-spot device market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A remote blood draw dried spot device is a medical tool used to collect small blood samples from patients remotely, often in home settings, by applying the blood onto specialized filter paper or absorbent material. The collected dried blood spots can then be safely transported to a laboratory for testing, allowing convenient monitoring of health parameters without the need for traditional venous blood draws.
The main product types of remote blood draw dried spot devices include filter paper devices, microfluidic devices, and others. Filter paper devices are designed to collect and preserve small blood samples on treated paper, providing a convenient, stable, and easily transportable method for dried blood spot testing. The supported sample types include whole blood, plasma, serum, and others, and these products are distributed through direct sales, online retail, pharmacies, and other channels. They are used in various applications such as disease diagnosis, therapeutic drug monitoring, newborn screening, forensic testing, and others, and serve end users including hospitals and clinics, diagnostic laboratories, research institutes, home care settings, and others.
The remote blood-draw dried-spot device market consists of sales of capillary blood collection kits, prepaid sample mailers, and integrated smart collection devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The remote blood-draw dried-spot device market size is expected to see rapid growth in the next few years. It will grow to $1.73 billion in 2030 at a compound annual growth rate (CAGR) of 13.2%. The growth in the forecast period can be attributed to home healthcare expansion, chronic disease monitoring, digital pathology growth, logistics optimization, population health management. Major trends in the forecast period include at-home blood sample collection, mail-in diagnostic testing, minimal invasive sampling devices, microfluidic blood collection, decentralized diagnostic testing.
The growing emphasis on personalized medicine is expected to drive the growth of the remote blood-draw dried-spot device market in the coming years. Personalized medicine involves tailoring medical treatments and preventive strategies based on an individual’s unique genetic, molecular, and clinical characteristics to achieve better health outcomes. The adoption of personalized medicine is increasing as advances in genomics make it possible to identify genetic variations that influence disease susceptibility and treatment response, enabling more targeted and effective therapies. Remote blood-draw dried-spot devices support this approach by allowing convenient, at-home collection of small blood samples, facilitating frequent monitoring of biomarkers and genetic information to guide individualized treatment decisions. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, the FDA approved 16 new personalized treatments for rare disease patients in 2023, up from six in 2022. These approvals included seven cancer therapies and three for other conditions. Therefore, the rising focus on personalized medicine is driving the growth of the remote blood-draw dried-spot device market.
Major companies in the remote blood-draw dried-spot device market are developing advanced decentralized sampling solutions to enable at-home blood collection, enhance patient convenience, and improve clinical trial efficiency. Decentralized sampling involves collecting biological samples outside traditional clinical settings, such as at home or in local facilities, allowing broader participation, faster sample turnaround, and improved data accessibility. For example, in March 2025, Tasso Inc., a US-based healthcare technology company, introduced next-generation dried blood spot (DBS) sampling technology designed for clinical trials and sports anti-doping testing. This innovation provides a virtually painless, accurate, and user-friendly method for blood collection, enabling precise volumetric sampling and high-quality data generation. By simplifying the sampling process and reducing participation barriers, the technology enhances compliance, accelerates drug development, and supports decentralized healthcare and research models.
In April 2025, Boston, a US-based biotechnology company, partnered with Nanowear Inc. to develop advanced wearable biosensors for continuous health monitoring. The collaboration aims to transform home-based healthcare by integrating AI-powered nanotechnology diagnostics with blood-based sampling and drug delivery patches. This combined digital health platform enables precise, continuous, and patient-friendly diagnostics and therapeutics, promoting the shift from clinic-centered to decentralized personalized care. Nanowear Inc., a US-based technology company, offers remote blood-draw dried-spot devices that complement these innovations in wearable biosensing and digital health monitoring.
Major companies operating in the remote blood-draw dried-spot device market are Neoteryx Inc., DBS System SA, Tasso Inc., Capitainer AB, Spot On Sciences Inc., HemaXis S.A., Drawbridge Health Inc., RDA Spot Inc., YourBio Health Inc., Lipomic Healthcare Inc., Trajan Scientific and Medical Pty Ltd., Salimetrics LLC, Eastern Business Forms Inc., PanoHealth Inc., RedDrop Dx Inc., Nanowear Inc., Bioanalytical Systems Inc., Phenomenex Inc., Greiner Bio-One International GmbH, Whatman (Cytiva)
North America was the largest region in the remote blood-draw dried-spot device market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the remote blood-draw dried-spot device market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the remote blood-draw dried-spot device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have increased costs of microfluidic components, filter papers, and plastic consumables used in dried-spot blood collection devices, particularly affecting manufacturers in Asia-Pacific supplying global markets. While tariffs have raised operational costs, they are also accelerating regional production, eco-friendly materials, and innovation in compact diagnostic sampling solutions.
The remote blood-draw dried-spot device market research report is one of a series of new reports that provides remote blood-draw dried-spot device market statistics, including remote blood-draw dried-spot device industry global market size, regional shares, competitors with a remote blood-draw dried-spot device market share, detailed remote blood-draw dried-spot device market segments, market trends and opportunities, and any further data you may need to thrive in the remote blood-draw dried-spot device industry. This remote blood-draw dried-spot device market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A remote blood draw dried spot device is a medical tool used to collect small blood samples from patients remotely, often in home settings, by applying the blood onto specialized filter paper or absorbent material. The collected dried blood spots can then be safely transported to a laboratory for testing, allowing convenient monitoring of health parameters without the need for traditional venous blood draws.
The main product types of remote blood draw dried spot devices include filter paper devices, microfluidic devices, and others. Filter paper devices are designed to collect and preserve small blood samples on treated paper, providing a convenient, stable, and easily transportable method for dried blood spot testing. The supported sample types include whole blood, plasma, serum, and others, and these products are distributed through direct sales, online retail, pharmacies, and other channels. They are used in various applications such as disease diagnosis, therapeutic drug monitoring, newborn screening, forensic testing, and others, and serve end users including hospitals and clinics, diagnostic laboratories, research institutes, home care settings, and others.
The remote blood-draw dried-spot device market consists of sales of capillary blood collection kits, prepaid sample mailers, and integrated smart collection devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Remote Blood-Draw Dried-Spot Device Market Characteristics
3. Remote Blood-Draw Dried-Spot Device Market Supply Chain Analysis
4. Global Remote Blood-Draw Dried-Spot Device Market Trends and Strategies
5. Remote Blood-Draw Dried-Spot Device Market Analysis of End Use Industries
7. Global Remote Blood-Draw Dried-Spot Device Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Remote Blood-Draw Dried-Spot Device Total Addressable Market (TAM) Analysis for the Market
9. Remote Blood-Draw Dried-Spot Device Market Segmentation
10. Remote Blood-Draw Dried-Spot Device Market Regional and Country Analysis
11. Asia-Pacific Remote Blood-Draw Dried-Spot Device Market
12. China Remote Blood-Draw Dried-Spot Device Market
13. India Remote Blood-Draw Dried-Spot Device Market
14. Japan Remote Blood-Draw Dried-Spot Device Market
15. Australia Remote Blood-Draw Dried-Spot Device Market
16. Indonesia Remote Blood-Draw Dried-Spot Device Market
17. South Korea Remote Blood-Draw Dried-Spot Device Market
18. Taiwan Remote Blood-Draw Dried-Spot Device Market
19. South East Asia Remote Blood-Draw Dried-Spot Device Market
20. Western Europe Remote Blood-Draw Dried-Spot Device Market
21. UK Remote Blood-Draw Dried-Spot Device Market
22. Germany Remote Blood-Draw Dried-Spot Device Market
23. France Remote Blood-Draw Dried-Spot Device Market
24. Italy Remote Blood-Draw Dried-Spot Device Market
25. Spain Remote Blood-Draw Dried-Spot Device Market
26. Eastern Europe Remote Blood-Draw Dried-Spot Device Market
27. Russia Remote Blood-Draw Dried-Spot Device Market
28. North America Remote Blood-Draw Dried-Spot Device Market
29. USA Remote Blood-Draw Dried-Spot Device Market
30. Canada Remote Blood-Draw Dried-Spot Device Market
31. South America Remote Blood-Draw Dried-Spot Device Market
32. Brazil Remote Blood-Draw Dried-Spot Device Market
33. Middle East Remote Blood-Draw Dried-Spot Device Market
34. Africa Remote Blood-Draw Dried-Spot Device Market
36. Remote Blood-Draw Dried-Spot Device Market Competitive Landscape and Company Profiles
37. Remote Blood-Draw Dried-Spot Device Market Other Major and Innovative Companies
40. Remote Blood-Draw Dried-Spot Device Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Remote Blood-Draw Dried-Spot Device Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses remote blood-draw dried-spot device market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for remote blood-draw dried-spot device? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The remote blood-draw dried-spot device market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Filter Paper Devices; Microfluidic Devices; Other Product Types2) By Sample Type: Whole Blood; Plasma; Serum; Other Sample Types
3) By Distribution Channel: Direct Sales; Online Retail; Pharmacies; Other Distribution Channels
4) By Application: Disease Diagnosis; Therapeutic Drug Monitoring; Newborn Screening; Forensic Testing; Other Applications
5) By End User: Hospitals And Clinics; Diagnostic Laboratories; Research Institutes; Home Care Settings; Other End-Users
Subsegments:
1) By Filter Paper Devices: Whole Blood Collection Cards; Plasma Separation Cards2) By Microfluidic Devices: Integrated Microchannel Systems; Capillary-Driven Microfluidic Chips
3) By Other Product Types: Volumetric Absorptive Micro sampling Devices; Capillary Blood Collection Tubes
Companies Mentioned: Neoteryx Inc.; DBS System SA; Tasso Inc.; Capitainer AB; Spot On Sciences Inc.; HemaXis S.A.; Drawbridge Health Inc.; RDA Spot Inc.; YourBio Health Inc.; Lipomic Healthcare Inc.; Trajan Scientific and Medical Pty Ltd.; Salimetrics LLC; Eastern Business Forms Inc.; PanoHealth Inc.; RedDrop Dx Inc.; Nanowear Inc.; Bioanalytical Systems Inc.; Phenomenex Inc.; Greiner Bio-One International GmbH; Whatman (Cytiva)
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Remote Blood-Draw Dried-Spot Device market report include:- Neoteryx Inc.
- DBS System SA
- Tasso Inc.
- Capitainer AB
- Spot On Sciences Inc.
- HemaXis S.A.
- Drawbridge Health Inc.
- RDA Spot Inc.
- YourBio Health Inc.
- Lipomic Healthcare Inc.
- Trajan Scientific and Medical Pty Ltd.
- Salimetrics LLC
- Eastern Business Forms Inc.
- PanoHealth Inc.
- RedDrop Dx Inc.
- Nanowear Inc.
- Bioanalytical Systems Inc.
- Phenomenex Inc.
- Greiner Bio-One International GmbH
- Whatman (Cytiva)
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.05 Billion |
| Forecasted Market Value ( USD | $ 1.73 Billion |
| Compound Annual Growth Rate | 13.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
